Fundraising Fox
Kezar Life Sciences
South San Francisco, US · Founded 2015 · Delaware corporation · 10 known investors
Find your way into Kezar Life Sciences
Sign up to see every warm intro you have to Kezar Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kezar Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
Founders & leadership
Kezar Life Sciences was founded in 2015 by John F. Fowler and Christopher J. Kirk.
Board
Investors · 10
How we know: funding news · press coverage · Not right? Tell us
How we know: Chiesi Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pappas Capital's portfolio page · Not right? Tell us
How we know: Qiming Venture Partners USA's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$78.4M disclosed across 2 rounds · 2015–2017
▶$50MraisedAug 2017 · 24 investors · BiotechnologyRule 506(b)
- Jean-Pierre SommadossiDirector
- Gerald ChanDirector
- Michael KauffmanDirector
- John F FowlerExecutive Officer, Director
- Franklin BergerDirector
- Christopher J KirkExecutive Officer, Director
- Bihua ChenDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$28.4MraisedJun 2015 · 49 investors · BiotechnologyRule 506(b)
- John F. FowlerExecutive Officer, Director
- Dr. Gerald ChanDirector
- Dr. Jean-Pierre SommadossiDirector
- Christopher J. KirkExecutive Officer, Director
- Offering amount
- $28.4M
- Amount sold
- $28.4M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Kezar Life Sciences do?
- Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
- Who founded Kezar Life Sciences?
- Kezar Life Sciences was founded by John F. Fowler, Christopher J. Kirk in 2015.
- Who are Kezar Life Sciences's investors?
- Kezar Life Sciences's investors include Bay City Capital, Chiesi Ventures, Pappas Capital, Qiming Venture Partners USA, Solasta Ventures, Cowen Healthcare Investments, EcoR1 Capital, Qiming Venture Partners.
- How much funding has Kezar Life Sciences raised?
- Kezar Life Sciences has disclosed $78.4M raised across 2 rounds.
- Where is Kezar Life Sciences headquartered?
- Kezar Life Sciences is headquartered in South San Francisco, US.